BOB (psychedelic)

BOB
Clinical data
Other names	β-Methoxy-2C-B; 4-Bromo-2,5,β-trimethoxyphenethylamine; β-MeO-2C-D
Routes of; administration	Oral
Drug class	Serotonin receptor modulator; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Pharmacokinetic data
Duration of action	10–20 hours
Identifiers
	IUPAC name 2-(4-bromo-2,5-dimethoxyphenyl)-2-methoxyethan-1-amine;
CAS Number	98537-42-9 ;
PubChem CID	15185771;
ChemSpider	21106261 ;
UNII	89A0HNR42S;
ChEMBL	ChEMBL191051 ;
CompTox Dashboard (EPA)	DTXSID60569805 ;
Chemical and physical data
Formula	C11H16BrNO3
Molar mass	290.157 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COc1cc(c(cc1Br)OC)C(CN)OC;
	InChI InChI=1S/C11H16BrNO3/c1-14-9-5-8(12)10(15-2)4-7(9)11(6-13)16-3/h4-5,11H,6,13H2,1-3H3 ; Key:FYTLQNZPDWLGNU-UHFFFAOYSA-N ;
	(verify)

BOB, also known as 4-bromo-2,5,β-trimethoxyphenethylamine or as β-methoxy-2C-B, is a psychedelic drug of the phenethylamine, 2C, and BOx families. It is the β-methoxy derivative of 2C-B. BOB was first synthesized by Alexander Shulgin.